Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies

A Zhao, H Zhou, J Yang, M Li, T Niu - Signal Transduction and Targeted …, 2023 - nature.com
Hematologic malignancies are one of the most common cancers, and the incidence has
been rising in recent decades. The clinical and molecular features of hematologic …

Recent findings on thymoquinone and its applications as a nanocarrier for the treatment of cancer and rheumatoid arthritis

RR Pal, V Rajpal, P Singh, SA Saraf - Pharmaceutics, 2021 - mdpi.com
Cancer causes a considerable amount of mortality in the world, while arthritis is an
immunological dysregulation with multifactorial pathogenesis including genetic and …

Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia

CL Hu, BY Chen, Z Li, T Yang, CH Xu, R Yang, PC Yu… - Cell research, 2022 - nature.com
Aberrant self-renewal of leukemia initiation cells (LICs) drives aggressive acute myeloid
leukemia (AML). Here, we report that UHRF1, an epigenetic regulator that recruits DNMT1 to …

Good cop, bad cop: Polyamines play both sides in host immunity and viral replication

YE Cruz-Pulido, BC Mounce - Seminars in Cell & Developmental Biology, 2023 - Elsevier
Viruses rely on host cells for energy and synthesis machinery required for genome
replication and particle assembly. Due to the dependence of viruses on host cells, viruses …

Thymoquinone is a multitarget single epidrug that inhibits the UHRF1 protein complex

O Abdullah, Z Omran, S Hosawi, A Hamiche, C Bronner… - Genes, 2021 - mdpi.com
Silencing of tumor suppressor genes (TSGs) through epigenetic mechanisms, mainly via
abnormal promoter DNA methylation, is considered a main mechanism of tumorigenesis …

In Vitro and In Vivo Preventive Effects of Thymoquinone against Breast Cancer: Role of DNMT1

M Kaleem, A Kayali, RA Sheikh, A Kuerban… - Molecules, 2024 - mdpi.com
Breast cancer (BC) is one of the most common cancers in women and is a major cause of
female cancer-related deaths. BC is a multifactorial disease caused by the dysregulation of …

Combinatorial effect of thymoquinone with chemo agents for tumor therapy

S Jehan, J Huang, U Farooq, I Basheer, W Zhou - Phytomedicine, 2022 - Elsevier
Background Most chemotherapeutics used in cancer therapies exhibit considerable side
effects to the patients. Thus, developing new chemo agents to treat cancer patients with …

Macrophage migration inhibitory factor in the pathogenesis of leukemia

Y Luo, X Wang, J Shen, J Yao - … Journal of Oncology, 2021 - spandidos-publications.com
Leukemia is a group of malignant diseases of clonal hematopoietic stem‑progenitor cells
and its pathological mechanisms remain to be elucidated. Genetic and epigenetic …

Pro-Apoptotic Potential of Pseudevernia furfuracea (L.) Zopf Extract and Isolated Physodic Acid in Acute Lymphoblastic Leukemia Model In Vitro

M Kello, T Kuruc, K Petrova, M Goga, Z Michalova… - Pharmaceutics, 2021 - mdpi.com
Acute lymphoblastic leukemia (ALL) is the most frequently diagnosed type of leukemia
among children. Although chemotherapy is a common treatment for cancer, it has a wide …

Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia

SS Hussan, MS Ali, M Fatima, M Altaf, S Sadaf - Annals of Hematology, 2024 - Springer
Abstract The NOTCH-Delta-HES signaling cascade is regarded as a double-edged sword
owing to its dual tumor-suppressor and oncogenic roles, in different cellular environments. In …